Project Details
Description
Development of SBI-553, an Allosteric Modulator of NTR1, for the Treatment of Substance Use Disorders
| Status | Finished |
|---|---|
| Effective start/end date | 9/15/23 → 8/31/25 |
Funding
- SANFORD-BURNHAM MEDICAL RESEARCH INST.
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.